The PARK7 Knockout Raji Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal population derived from the human Burkitt??s lymphoma B lymphocyte line Raji, with targeted disruption of the PARK7 gene. This loss-of-function model enables the study of DJ-1 protein function in a lymphoblastoid setting, offering a mixed genotype pool that reflects population-level heterogeneity. Unlike clonal isolates, the polyclonal knockout approach maintains diverse genetic backgrounds, providing a robust tool for investigating PARK7-dependent pathways without the confounding effects of single-cell clonal selection.
The Raji cell line, originally established from an Epstein-Barr virus (EBV)-positive Burkitt??s lymphoma patient, is an immortalized B lymphocyte line widely used in immunology and hematological cancer research. As a lymphoblastoid cell line, Raji cells provide a surrogate model for B-cell biology, lymphomagenesis, and EBV-mediated oncogenesis. The presence of EBV contributes to altered redox homeostasis and constitutive activation of survival pathways, making these cells particularly relevant for dissecting the antioxidant and anti-apoptotic roles of PARK7 in a transformation-relevant context.
PARK7 encodes DJ-1, a redox-sensitive chaperone and transcriptional co-regulator that protects cells from oxidative stress and mitochondrial dysfunction. DJ-1 stabilizes Nrf2 to activate antioxidant gene expression via the Nrf2/KEAP1/ARE pathway and inhibits PTEN, sustaining Akt-mediated survival signaling. It interacts with Parkin and PINK1 to preserve mitochondrial integrity, and forms complexes with ASK1, p53, Daxx, and SUMO-1 to modulate stress-induced apoptosis. Upstream regulators include oxidative stress, Nrf2, PI3K/Akt, c-Myc, and HIF-1??; downstream, DJ-1 protects mitochondrial complex I and promotes anti-apoptotic Bcl-xL expression.
In the Raji B lymphocyte background, knockout of PARK7 disrupts the intricate balance between oxidative stress response and survival signaling. Given the elevated basal oxidative stress in EBV-transformed B cells and the reliance on DJ-1 for Nrf2 activation and Akt pro-survival signaling, this model is particularly suited for dissecting the contribution of PARK7 to lymphomagenesis, chemoresistance, and mitochondrial homeostasis. The polyclonal knockout population allows interrogation of these mechanisms without clonal bias, reflecting the heterogeneity inherent in tumor cell populations.
This PARK7 knockout Raji model enables investigation of oxidative stress response, mitochondrial quality control, and Parkinson??s disease pathogenesis in a B-cell context. It facilitates cancer biology studies on DJ-1-mediated survival signaling, apoptosis resistance, and chemoresistance in B-cell lymphoma. Common assays include immunoblotting, RT-qPCR, ROS and mitochondrial membrane potential measurements, Nrf2 reporter analysis, and flow cytometry for oxidative stress and apoptosis. The polyclonal nature supports drug screening campaigns targeting antioxidant and oncogenic pathways. For further information, please contact Ascent Research.
